Mostly Markets
Subscribe
Stocks/Health Care/Health Care Supplies

Align TechnologyALGN

Health Care Supplies · Tempe, Arizona · In the S&P 500
Solid businessCheaper than peers
$149.89−2.49%After hours: $149.89 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 13.6% over 1 year
Align Technology over 1 yearDaily close, $, to 30 Oct 2026
$140$160$180$200Nov2026MarMayJulSep$149.89$175$200NovMarJul$149.89
Source: Nasdaq daily closes
Market value$10.65B
Price to earnings21.8x
Forward P/E12.9x
Dividend yield–
Year to date−4.0%
One year+13.6%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$132.28$197.51

Quality and valuation

How Align Technology compares with other health care stocks. A description, not a recommendation.

Align Technology and 5 health care supplies peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: cheaper than most

An average business among health care companies, priced below most of them.

Align Technology trades at 12.9 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +4.4% vs +7.8%
  • Keeps more of each sale (gross margin): 68.0% vs 65.3%
  • Less profitable (operating margin): 13.2% vs 13.3%
  • Turns less of its sales into cash: 15.3% vs 15.9%
ALGN trades at 12.9x forward earnings, below the sector medianForward p/e, Health Care Supplies peers
ALGN12.9xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1xALGN12.9xNVS17.0xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 26.1x earnings, ALGN is cheaper than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
30x40xAverage 31.4x2025202626.1x30x40xAverage 31.4x2025202626.1x
Source: Nasdaq prices; SEC filings

Financials

From Align Technology's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 4.3% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0.0bn$0.5bn$1.0bnQ3 ’24Q1 ’25Q3 ’25$1.1bnQ2 ’26$0.0bn$0.5bn$1.0bnQ3 ’24Q1 ’25Q3 ’25$1.1bnQ2 ’26
Source: SEC filings
Growth slowed to +4.3% last quarterRevenue growth, year on year, %
0%2%4%6%Q3 ’24Q1 ’25Q3 ’254.3%Q2 ’260%5%Q3 ’24Q1 ’25Q3 ’254.3%Q2 ’26
Source: SEC filings
Operating margin was 14.6% last quarterOperating income as a share of revenue, %
0%5%10%15%Q3 ’24Q1 ’25Q3 ’2514.6%Q2 ’260%10%Q3 ’24Q1 ’25Q3 ’2514.6%Q2 ’26
Source: SEC filings
Free cash flow was $634 million over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$100m$200mQ3 ’24Q1 ’25Q3 ’25$157mQ2 ’26$0m$100m$200mQ3 ’24Q1 ’25Q3 ’25$157mQ2 ’26
Source: SEC filings
Last 12 monthsALGNSector median
Revenue growth+4.4%+7.8%
Gross margin68.0%65.3%
Operating margin13.2%13.3%
Free cash flow margin15.3%15.9%
Price to earnings21.8x30.2x

Stories on Align Technology

We haven't written about Align Technology yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Supplies, by market value.

CompanyPriceTodayYTDValue
LLYEli Lilly$1,417.54+3.19%+31.9%$1.33T
JNJJohnson & Johnson$273.20−0.73%+32.0%$658B
ABBVAbbVie$294.89+1.41%+29.1%$521B
MRKMerck$149.52+2.18%+42.0%$369B
UNHUnitedHealth$406.97−0.96%+23.3%$365B
NVSNovartis$160.79−0.19%+16.6%$327B
AZNAstraZeneca$186.65+7.02%+6.4%$290B
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B